Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial OF Oxaliplatin and Gemcitabine With Bevacizumab in Advanced Non-Small Cell Lung Cancer

NCT00217282 is registered in ClinicalTrials.gov with Mt. Sinai Medical Center, Miami as lead sponsor.

NCT NCT00217282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00217282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial OF Oxaliplatin and Gemcitabine With Bevacizumab in Advanced Non-Small Cell Lung Cancer
Lead sponsor
Mt. Sinai Medical Center, Miami
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2004
Completion date
March 31, 2008
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer